Literature DB >> 6147814

Vasoactive intestinal polypeptide (VIP): current status.

S I Said.   

Abstract

Research on VIP continues at a rapid pace. Recent progress includes: insights into its biosynthesis (and that of a closely related PHI-like peptide) and its neuronal localization, discovery of novel biological actions, new data on its release and binding to specific receptors, and additional evidence for its roles in physiological regulation and in the pathogenesis of disease.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147814     DOI： 10.1016/0196-9781(84)90197-9

Source DB:  PubMed          Journal:  Peptides        ISSN： 0196-9781            Impact factor:   3.750


  24 in total

1.  Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.

Authors:  L G Guijarro; A Couvineau; M S Rodriguez-Pena; M G Juarranz; N Rodriguez-Henche; E Arilla; M Laburthe; J C Prieto
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 3.  Roles of mast cell proteases in airways.

Authors:  J A Nadel
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.

Authors:  J M Martin; H Darbon; J Luis; A el Battari; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 5.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

6.  Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.

Authors:  G Ciabattoni; P Montuschi; D Currò; G Togna; P Preziosi
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters.

Authors:  A R Diani; T Peterson; G A Sawada; B M Wyse; M C Blanks; G C Gerritsen; G Terenghi; I M Varndell; J M Polak; M A Blank
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

8.  Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.

Authors:  D E Hu; C R Hiley; T P Fan
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.

Authors:  A el Battari; P Forget; F Fouchier; P Pic
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

10.  Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

Authors:  S Fujieda; J A Waschek; K Zhang; A Saxon
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.